KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 259 filers reported holding KARUNA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.43 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,348,477 | -29.0% | 61,201 | -8.9% | 0.07% | -30.5% |
Q2 2023 | $14,572,537 | +29.7% | 67,201 | 0.0% | 0.10% | +34.6% |
Q1 2023 | $11,235,114 | -30.4% | 67,201 | -18.2% | 0.08% | -28.4% |
Q4 2022 | $16,151,740 | -12.6% | 82,201 | 0.0% | 0.11% | -16.2% |
Q3 2022 | $18,490,000 | +64.7% | 82,201 | -7.4% | 0.13% | +41.3% |
Q2 2022 | $11,224,000 | +42.6% | 88,727 | +42.9% | 0.09% | +70.4% |
Q1 2022 | $7,873,000 | +215.4% | 62,095 | +225.9% | 0.05% | +237.5% |
Q4 2021 | $2,496,000 | -62.7% | 19,056 | -65.2% | 0.02% | -65.2% |
Q3 2021 | $6,697,000 | +7.3% | 54,750 | 0.0% | 0.05% | +7.0% |
Q2 2021 | $6,241,000 | – | 54,750 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 908,708 | $109,254,000 | 35.05% |
Sofinnova Investments, Inc. | 1,952,441 | $234,742,000 | 14.11% |
Logos Global Management LP | 200,000 | $24,046,000 | 2.35% |
First Light Asset Management, LLC | 258,500 | $31,079,000 | 2.06% |
Eventide Asset Management | 971,077 | $116,753,000 | 1.73% |
DAFNA Capital Management LLC | 48,000 | $5,771,000 | 1.37% |
CATALYST PRIVATE WEALTH, LLC | 13,006 | $1,564,000 | 1.10% |
Rock Springs Capital Management LP | 368,764 | $44,336,000 | 0.97% |
Pinz Capital Management, LP | 28,805 | $3,463,000 | 0.92% |
MILLER VALUE PARTNERS, LLC | 291,239 | $35,016,000 | 0.91% |